The WSJ confirms that Merck is "desperate" for funding streams and "vaccination across the U.S. would make Gardasil an automatic blockbuster." Continue reading →
Pharma
Reputations for Sale ? BMJ-BBC-Panorama-Seroxat/ Paxil
BBC-Panorama–third in a series: The Secrets of Seroxat. "In the interests of patients and professional integrity" is to show those who have sold their reputations "intolerance and exposure." Continue reading →
Showdown Looms in Congress Over Drug Advertising on TV
The FDA is salivating in expectation of increased funding from the drug industry–ostensibly to speed up the reviewing process for TV ads.
Pfizer CEO Urges Staff to Mobilize & Lobby Congress Against Drug Price Controls
To gain insight into how a pharmaceutical giant is revving up itsr troops to lobby Congress against the legislation. See Pfizer CEO’s directive to the entire staff exhorting them to mobilize and lobby Congress to vote against drug price controls. http://www.pfizerfactfiction.com/mma/flash.html
DRUG FILES SHOW LILLY PROMOTED ZYPREXA FOR UNAPPROVED USE
THE NEW YORK TIMES EXPOSE OF ELI LILLY SECRET ZYPREXA DOCUMENTS Part II.
Big Pharma Cashing In Like Robber Barrons on Medicare Rx Drug Law_NYT
The New York Times reports: "For big drug companies, the new Medicare prescription benefit is proving to be a financial windfall larger than even the most optimistic Wall Street analysts had predicted."
FDA Says Bayer Failed to Reveal Lethal Drug Risks–but Fails to Change Licensure or Label_NYT
FDA issued an advisory stating that the concealed study results demonstrate "that use of Trasylol may increase the chance for death, serious kidney damage, congestive heart failure and strokes."
Scarborough Revisits Bayer Marketing AIDS-infected blood clotting substance
Recently, MSNBC’s Joe Scarborough revisited a shocking investigative news report by New York Times reporters, WALT BOGDANICH AND ERIC KOLI, published May 22, 2003.
Continue reading →
Tylenol Toxicity: Big Bucks in Long War on Aspirin_Counterpunch
Yesterday we forwarded an article about Tylenol-linked liver damage published by Associated Press. https://www.ahrp.org/cms/content/view/278/28/
Below two recent reports by Counterpunch.
Continue reading →
State Licensing drug reps could regulate sales policies
A ray of hope that might help cleanse medicine of its corrupt interaction with drug company marketers.
Continue reading →
Some Doctors Object to PhRMA Snooping-NYT_Phil Maher: Pill Popping Nation-LAT
“The sale of the master file to drug companies hands the weapon to the drug company that the A.M.A. is saying is an illicit weapon." Continue reading →
Glaxo denies “disease mongering”_Selling Bipolar questioned_PLoS
Under the influence of pharmaceutical companies, physicians anhd drug companies engage in "disease mongering." Below is a critique of Dr. David Healy’s essay: Dr. Nassir Ghaemi who argues for the legitimacy of bipolar diagnosis. Continue reading →